|
Click here to view online. Add this email to your safelist. |
|||||||||||
|
|
|||||||||||
|
Update on the MESSINA Phase III trial for Fasenra in eosinophilic esophagitis |
|||||||||||
|
|
|||||||||||
|
25 October 2022
Eosinophilic esophagitis (EoE) is a rare, progressive, chronic inflammatory disease of the esophagus currently believed to be characterised by the abnormal presence of eosinophils, a type of white blood cell, in the inner lining of the esophagus. Patients experience difficulty with swallowing (dysphagia), pain, food getting stuck and anxiety |
|||||||||||
|